The biggest challenge for a biopharmaceutical company is to provide a high-quality product in a cost-efficient manner. The necessity to harness the first-to-market advantage similarly as meet the growing pressure to manage prices from customers, insurance firms and governments has led several biopharmaceutical manufacturers to resort to innovative ways of production. Implementation of process intensification (continuous manufacturing) and use of disposable technologies has significantly boosted the assembly productivities. Integration of applied mathematics modeling with commonplace bioprocess improvement strategies has also been a positive strategy in achieving the goals of quicker production time and better method design.

Leave a Reply

Your email address will not be published. Required fields are marked *

The biggest challenge for a biopharmaceutical company is to provide a high-quality product in a cost-efficient manner. The necessity to harness the first-to-market advantage similarly as meet the growing pressure to manage prices from customers, insurance firms and governments has led several biopharmaceutical manufacturers to resort to innovative ways of production. Implementation of process intensification (continuous manufacturing) and use of disposable technologies has significantly boosted the assembly productivities. Integration of applied mathematics modeling with commonplace bioprocess improvement strategies has also been a positive strategy in achieving the goals of quicker production time and better method design.

Leave a Reply

Your email address will not be published. Required fields are marked *